Header Logo

Connection

MICHELLE A FANALE to CD40 Antigens

Back to Details
This is a "connection" page, showing publications MICHELLE A FANALE has written about CD40 Antigens.
MICHELLE A FANALE
Connection Strength
0.429
CD40 Antigens
  1. Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma. Br J Haematol. 2014 Jan; 164(2):258-65.
    View in: PubMed
    Score: 0.429
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.